Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 466 to 480 of 1876 results for do not dos

  1. Lung cancer in adults (QS17)

    This quality standard covers diagnosing and managing lung cancer in adults. It describes high-quality care in priority areas for improvement.

    Quality standard
    Last updated
    13 December 2019
    View quality statements

    Sections for QS17

  2. Autism (QS51)

    This quality standard covers health and social care services for adults, young people and children with autism. It includes assessment and diagnosis of autism spectrum disorders, and care and support for people diagnosed with an autism spectrum disorder. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    21 January 2014
    View quality statements

    Sections for QS51

  3. Colorectal cancer . Patient decision aid on Lynch syndrome: should I take aspirin to reduce my chance of getting bowel cancer?

    aspirin or not. Your specialist team will tell you what other things you can do to reduce your risk of bowel and other cancers. It is...

  4. Transcutaneous microwave ablation for severe primary axillary hyperhidrosis (HTG458)

    Evidence-based recommendations on transcutaneous microwave ablation for severe primary axillary hyperhidrosis in adults. This involves using microwaves to destroy sweat glands in the armpit.

    HealthTech guidance
    Published
    20 December 2017
    View recommendations

    Sections for HTG458

  5. Durvalumab with etoposide and either carboplatin or cisplatin for untreated extensive-stage small-cell lung cancer (TA1041)

    Evidence-based recommendations on durvalumab (Imfinzi) with etoposide and either carboplatin or cisplatin for untreated extensive-stage small-cell lung cancer in adults.

    Technology appraisal guidance
    Published
    19 February 2025
    View recommendations

    Sections for TA1041

  6. Delirium assessment tools:What is the diagnostic accuracy, and ease of implementation, of different delirium assessment tools: for people with pre-existing cognitive impairment, for example dementia, learning disability or severe depression for people who do not speak English as a first language in different settings, for example emergency departments, residential care homes or virtual consultations when delivered by different types of health and social care practitioners, for example healthcare assistants or allied health professionals such as paramedics?

    example dementia, learning disability or severe depression for people who do not speak English as a first language in different...

    Research recommendation
    Published
    3 February 2023

  7. Vitamin D: supplement use in specific population groups (PH56)

    This guideline covers vitamin D supplement use. It aims to prevent vitamin D deficiency among specific population groups including infants and children aged under 4, pregnant and breastfeeding women, particularly teenagers and young women, people over 65, people who have low or no exposure to the sun and people with dark skin.

    Public health guideline
    Last updated
    30 August 2017
    View recommendations

    Sections for PH56

  8. Ex-situ machine perfusion devices for lung transplants

    In development Reference number: GID-HTE10084 Expected publication date:  21 October 2026

    Health technology evaluations
    In development

  9. Uterine artery embolisation for treating adenomyosis (HTG324)

    Evidence-based recommendations on uterine artery embolisation for treating adenomyosis. This involves injecting small particles to block the blood supply to the adenomyosis (thickening of the womb lining).

    HealthTech guidance
    Published
    16 December 2013
    View recommendations

    Sections for HTG324

  10. Artificial intelligence (AI) and digital regulations service

    We're playing a leading role in the AI and digital regulations service which supports the development and adoption of AI and data-driven technologies in health and care.

  11. NICE recommended that further research should be designed to generate robust evidence of the clinical- and cost-effectiveness of Holoclar for treating both eyes in people with bilateral limbal stem cell deficiency after eye burns if they do not have enough tissue for a conjunctival limbal autograft. The study should recruit people with bilateral disease and evaluate the effectiveness of treatment in both eyes. Outcomes should include transplant success and assessments of health-related quality of life using a generic preference-based measure.

    people with bilateral limbal stem cell deficiency after eye burns if they do not have enough tissue for a conjunctival limbal autograft....

    Research recommendation
    Published
    15 October 2018

  12. Prucalopride for the treatment of chronic constipation in women (TA211)

    Evidence-based recommendations on prucalopride (Resolor) for treating chronic constipation in women.

    Technology appraisal guidance
    Published
    15 December 2010
    View recommendations

    Sections for TA211

  13. Aortic valve reconstruction with processed bovine pericardium (HTG461)

    Evidence-based recommendations on aortic valve reconstruction with processed bovine pericardium. This involves replacing a damaged aortic valve with a new valve made from chemically treated cow pericardium.

    HealthTech guidance
    Published
    14 February 2018
    View recommendations

    Sections for HTG461

  14. Surgical mesh for treatment of non-primary ventral hernias

    In development Reference number: GID-HTG10165 Expected publication date: TBC

    HealthTech guidance
    In development

  15. Urinary incontinence and pelvic organ prolapse in women. Patient decision aid on surgery for stress urinary incontinence

    years later, and it's not known for certain what all of them might be. If they do develop they might not trouble you very much, or they...